P4.14 RENAL DENERVATION IMPROVES CENTRAL HEMODYNAMICS AND PULSE PRESSURE AMPLIFICATION IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION

Background: Renal denervation (RDN) was shown to be effective in reducing peripheral BP in treatment resistant hypertension. Accumulating data suggest that central pressures may be a better predictor of cardiovascular events and outcomes than the corresponding peripheral pressure. PP amplification i...

Full description

Bibliographic Details
Main Authors: C. Ott, A. Schmid, T. Ditting, R. Veelken, M. Uder, R.E. Schmieder
Format: Article
Language:English
Published: Atlantis Press 2013-11-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125939010/view
id doaj-ba351ce1a8754d088a8597b73fb7b9f7
record_format Article
spelling doaj-ba351ce1a8754d088a8597b73fb7b9f72020-11-25T02:36:28ZengAtlantis PressArtery Research 1876-44012013-11-0171010.1016/j.artres.2013.10.132P4.14 RENAL DENERVATION IMPROVES CENTRAL HEMODYNAMICS AND PULSE PRESSURE AMPLIFICATION IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSIONC. OttA. SchmidT. DittingR. VeelkenM. UderR.E. SchmiederBackground: Renal denervation (RDN) was shown to be effective in reducing peripheral BP in treatment resistant hypertension. Accumulating data suggest that central pressures may be a better predictor of cardiovascular events and outcomes than the corresponding peripheral pressure. PP amplification is among others inversely related to stiffer arteries and peripheral arterial resistance. Methods: 57 patients with treatment resistant hypertension (office BP ≥140/90 mmHg, while on at least 3 antihypertensive agents, and diagnosis confirmed by 24-h ABPM ≥130/80 mmHg) underwent catheter-based RDN using the Symplicity FlexTM catheter (Medtronic Inc., Palo Alto, CA). In addition, in our lab pulse wave analysis was assessed with the SphygmoCorTM device (AtCor Medical, Australia) before and after 6 months of RDN. PP amplification is determined as ratio of peripheral PP to central PP. Results: Patients (59±12 years) were treated with 6.0±1.3 antihypertensive drugs on average. Peripheral as well as central systolic and diastolic BP were reduced (all p<0.01) 6 months after RDN. In accordance, peripheral PP (77.5±22 versus 71.5±23 mmHg, p=0.008) and central PP (63.2±21 versus 56.7±22 mmHg, p=0.001) were reduced 6 months after RDN. Consistently, there was a significant improvement in PP amplification (1.25±0.2 versus 1.30±0.2, p=0.012). Also central augmentation pressure (20±12 versus 16±13 mmHg, p<0.001) and cAIx@75 (24±10 versus 21±11 %, p=0.005) decreased 6 months after RDN. There was no change on heart rate (63±11 versus 64±10 bpm, p=0.499). Conclusion: Our data suggest that RDN might exert beneficial effects indicated by an improvement of central PP beyond peripheral PP, and hence PP amplification.https://www.atlantis-press.com/article/125939010/view
collection DOAJ
language English
format Article
sources DOAJ
author C. Ott
A. Schmid
T. Ditting
R. Veelken
M. Uder
R.E. Schmieder
spellingShingle C. Ott
A. Schmid
T. Ditting
R. Veelken
M. Uder
R.E. Schmieder
P4.14 RENAL DENERVATION IMPROVES CENTRAL HEMODYNAMICS AND PULSE PRESSURE AMPLIFICATION IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION
Artery Research
author_facet C. Ott
A. Schmid
T. Ditting
R. Veelken
M. Uder
R.E. Schmieder
author_sort C. Ott
title P4.14 RENAL DENERVATION IMPROVES CENTRAL HEMODYNAMICS AND PULSE PRESSURE AMPLIFICATION IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION
title_short P4.14 RENAL DENERVATION IMPROVES CENTRAL HEMODYNAMICS AND PULSE PRESSURE AMPLIFICATION IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION
title_full P4.14 RENAL DENERVATION IMPROVES CENTRAL HEMODYNAMICS AND PULSE PRESSURE AMPLIFICATION IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION
title_fullStr P4.14 RENAL DENERVATION IMPROVES CENTRAL HEMODYNAMICS AND PULSE PRESSURE AMPLIFICATION IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION
title_full_unstemmed P4.14 RENAL DENERVATION IMPROVES CENTRAL HEMODYNAMICS AND PULSE PRESSURE AMPLIFICATION IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION
title_sort p4.14 renal denervation improves central hemodynamics and pulse pressure amplification in patients with treatment resistant hypertension
publisher Atlantis Press
series Artery Research
issn 1876-4401
publishDate 2013-11-01
description Background: Renal denervation (RDN) was shown to be effective in reducing peripheral BP in treatment resistant hypertension. Accumulating data suggest that central pressures may be a better predictor of cardiovascular events and outcomes than the corresponding peripheral pressure. PP amplification is among others inversely related to stiffer arteries and peripheral arterial resistance. Methods: 57 patients with treatment resistant hypertension (office BP ≥140/90 mmHg, while on at least 3 antihypertensive agents, and diagnosis confirmed by 24-h ABPM ≥130/80 mmHg) underwent catheter-based RDN using the Symplicity FlexTM catheter (Medtronic Inc., Palo Alto, CA). In addition, in our lab pulse wave analysis was assessed with the SphygmoCorTM device (AtCor Medical, Australia) before and after 6 months of RDN. PP amplification is determined as ratio of peripheral PP to central PP. Results: Patients (59±12 years) were treated with 6.0±1.3 antihypertensive drugs on average. Peripheral as well as central systolic and diastolic BP were reduced (all p<0.01) 6 months after RDN. In accordance, peripheral PP (77.5±22 versus 71.5±23 mmHg, p=0.008) and central PP (63.2±21 versus 56.7±22 mmHg, p=0.001) were reduced 6 months after RDN. Consistently, there was a significant improvement in PP amplification (1.25±0.2 versus 1.30±0.2, p=0.012). Also central augmentation pressure (20±12 versus 16±13 mmHg, p<0.001) and cAIx@75 (24±10 versus 21±11 %, p=0.005) decreased 6 months after RDN. There was no change on heart rate (63±11 versus 64±10 bpm, p=0.499). Conclusion: Our data suggest that RDN might exert beneficial effects indicated by an improvement of central PP beyond peripheral PP, and hence PP amplification.
url https://www.atlantis-press.com/article/125939010/view
work_keys_str_mv AT cott p414renaldenervationimprovescentralhemodynamicsandpulsepressureamplificationinpatientswithtreatmentresistanthypertension
AT aschmid p414renaldenervationimprovescentralhemodynamicsandpulsepressureamplificationinpatientswithtreatmentresistanthypertension
AT tditting p414renaldenervationimprovescentralhemodynamicsandpulsepressureamplificationinpatientswithtreatmentresistanthypertension
AT rveelken p414renaldenervationimprovescentralhemodynamicsandpulsepressureamplificationinpatientswithtreatmentresistanthypertension
AT muder p414renaldenervationimprovescentralhemodynamicsandpulsepressureamplificationinpatientswithtreatmentresistanthypertension
AT reschmieder p414renaldenervationimprovescentralhemodynamicsandpulsepressureamplificationinpatientswithtreatmentresistanthypertension
_version_ 1724800019519766528